A novel anticoagulant activity assay of tissue factor pathway inhibitor I (TFPI).
Reduction of factor FVIIa activity during heparin therapy. Evidence for assay interactions with tissue factor pathway inhibitor and antithrombin.
A simple chromogenic substrate assay of tissue factor pathway inhibitor activity in plasma and serum.
Tissue factor pathway inhibitor activity in severe sepsis.
Creasey AA, Reinhart K.
Crit Care Med. 2001 Jul;29(7 Suppl):S126-9. doi: 10.1097/00003246-200107001-00038.
Relation between Tissue Factor Pathway Inhibitor Activity and Cardiovascular Risk Factors and Diseases in a Large Population Sample.
van Paridon PCS, Panova-Noeva M, van Oerle R, Schulz A, Prochaska JH, Arnold N, Schmidtmann I, Beutel M, Pfeiffer N, Münzel T, Lackner KJ, Hackeng TM, Ten Cate H, Wild PS, Spronk HMH.
Thromb Haemost. 2021 Feb;121(2):174-181. doi: 10.1055/s-0040-1715897. Epub 2020 Sep 2.
Disseminated Intravascular Coagulation: An Update on Pathogenesis, Diagnosis, and Therapeutic Strategies.
Papageorgiou C, Jourdi G, Adjambri E, Walborn A, Patel P, Fareed J, Elalamy I, Hoppensteadt D, Gerotziafas GT.
Clin Appl Thromb Hemost. 2018 Dec;24(9_suppl):8S-28S. doi: 10.1177/1076029618806424. Epub 2018 Oct 8.
Tissue factor pathway inhibitor: structure-function.
Broze GJ Jr, Girard TJ.
Front Biosci (Landmark Ed). 2012 Jan 1;17(1):262-80. doi: 10.2741/3926.
The Impact of Anticoagulant Activity of Tissue Factor Pathway Inhibitor Measured by a Novel Functional Assay for Predicting Deep Venous Thrombosis in Trauma Patients: A Prospective Nested Case-Control Study.
Cao X, Su Y, Zhang W, Zhao H, Wen M, Lu S, Zhao Y, Chen Y, Liu L, Zang X, Wu J.
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211063877. doi: 10.1177/10760296211063877.
Tissue factor pathway inhibitor: regulation of its inhibitory activity by phospholipid surfaces.
Lindhout T, Salemink I, Valentin S, Willems GM.
Haemostasis. 1996 Oct;26 Suppl 4:89-97. doi: 10.1159/000217289.
Tissue Factor Pathway Inhibitor: Multiple Anticoagulant Activities for a Single Protein.
Mast AE.
Arterioscler Thromb Vasc Biol. 2016 Jan;36(1):9-14. doi: 10.1161/ATVBAHA.115.305996. Epub 2015 Nov 24.
Tissue factor pathway inhibitor: then and now.
Ellery PE, Adams MJ.
Semin Thromb Hemost. 2014 Nov;40(8):881-6. doi: 10.1055/s-0034-1395153. Epub 2014 Nov 6.
Protein arginine deiminase 4 inactivates tissue factor pathway inhibitor-alpha by enzymatic modification of functional arginine residues.
Thomassen MCLGD, Bouwens BRC, Wichapong K, Suylen DP, Bouwman FG, Hackeng TM, Koenen RR.
J Thromb Haemost. 2023 May;21(5):1214-1226. doi: 10.1016/j.jtha.2023.01.017. Epub 2023 Jan 28.
Increased tissue factor pathway inhibitor activity in IDDM patients with nephropathy.
Yokoyama H, Myrup B, Rossing P, Ostergaard PB.
Diabetes Care. 1996 May;19(5):441-5. doi: 10.2337/diacare.19.5.441.
